SNDX · Forms 3, 4, 5
Insider trades at Syndax Pharmaceuticals Inc
No open-market insider buys or sells at Syndax Pharmaceuticals Inc in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Syndax Pharmaceuticals Inc (SNDX) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Syndax Pharmaceuticals Inc in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Michael A Metzger | Chief Executive Officer | Option exercise | 32,375 | $6.38 | $207K | Form 4 | |
| Michael A Metzger | Chief Executive Officer | Sell (10b5-1 plan) | 32,375 | $24.24 | $785K | Form 4 | |
| Nicholas A.J. Botwood | Head of R&D, CMO | Option exercise | 31,235 | $13.82 | $432K | Form 4 | |
| Nicholas A.J. Botwood | Head of R&D, CMO | Sell (10b5-1 plan) | 31,235 | $18.14 | $567K | Form 4 | |
| Nicholas A.J. Botwood | Head of R&D, CMO | Option exercise | 22,515 | $13.82 | $311K | Form 4 | |
| Nicholas A.J. Botwood | Head of R&D, CMO | Sell (10b5-1 plan) | 34,280 | $18.00 | $617K | Form 4 | |
| Keith A. Goldan | Chief Financial Officer | Sell | 1,177 | $18.99 | $22K | Form 4 | |
| Michael A Metzger | Chief Executive Officer | Sell | 6,847 | $18.99 | $130K | Form 4 | |
| Michael A Metzger | Chief Executive Officer | Sell | 17,159 | $21.03 | $361K | Form 4 | |
| Keith A. Goldan | Chief Financial Officer | Sell | 3,410 | $21.03 | $72K | Form 4 | |
| Michael A Metzger | Chief Executive Officer | Sell | 7,412 | $20.62 | $153K | Form 4 | |
| Keith A. Goldan | Chief Financial Officer | Sell | 2,082 | $20.62 | $43K | Form 4 | |
| Michael A Metzger | Chief Executive Officer | Award | 73,000 | Form 4 | |||
| Michael A Metzger | Chief Executive Officer | Award | 144,600 | Form 4 | |||
| Keith A. Goldan | Chief Financial Officer | Award | 21,500 | Form 4 | |||
| Keith A. Goldan | Chief Financial Officer | Award | 30,750 | Form 4 | |||
| Jennifer Jarrett | Director | Award | 24,000 | Form 4 | |||
| Martin H. Huber Jr. | Director | Award | 24,000 | Form 4 | |||
| Keith A. Goldan | Chief Financial Officer | Other | 1,219 | $8.48 | $10K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.